Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Details 5)

v3.8.0.1
STOCKHOLDERS' EQUITY (Details 5)
 3 Months Ended
Dec. 31, 2017
$ / shares
shares
Warrant One [Member]  
Exercise Price $ 5.25
Number of Shares | shares 2,539,061 [1]
Expiration Date 2022-07
Weighted Average Exercise Price $ 5.25
Warrant Two [Member]  
Exercise Price $ 5.25
Number of Shares | shares 1,675,000 [2]
Expiration Date 2022-07
Weighted Average Exercise Price $ 5.25
Warrant Three [Member]  
Exercise Price $ 5.25
Number of Shares | shares 213,800 [3]
Expiration Date 2022-07
Weighted Average Exercise Price $ 5.25
Warrant Four [Member]  
Exercise Price $ 6.04
Number of Shares | shares 134,000 [4]
Expiration Date 2022-07
Weighted Average Exercise Price $ 6.04
Warrant Five [Member]  
Exercise Price $ 9.44
Number of Shares | shares 191
Expiration Date 2018-03
Weighted Average Exercise Price $ 9.44
Warrant Six [Member]  
Exercise Price $ 10.00
Number of Shares | shares 4,000 [5]
Expiration Date 2021-06
Weighted Average Exercise Price $ 10.00
Warrant Seven [Member]  
Exercise Price $ 55.00
Number of Shares | shares 1,620
Weighted Average Exercise Price $ 55.00
Warrant Seven [Member] | Minimum [Member]  
Expiration Date 2018-06
Warrant Seven [Member] | Maximum [Member]  
Expiration Date 2019-03
Warrant [Member]  
Number of Shares | shares 4,567,672
Weighted Average Exercise Price $ 5.30
[1] On July 13, 2017, the Company declared a special dividend of warrants to purchase shares of the Company's common stock to record holders of Common Stock as of such date. Warrants to purchase 2,539,061 shares of Common Stock were distributed pro rata to all holders of common stock on the record date. These warrants will be exercisable (in accordance with their terms) to purchase one share of common stock, at an exercise price of $5.25 per share. The warrants will become exercisable commencing not less than 12 months following their July 27, 2017 distribution date and will expire five years thereafter.
[2] On July 19, 2017, the Company issued 1,675,000 shares of Common Stock and accompanying Warrants to purchase up to 1,675,000 shares of Common Stock in connection with an underwritten public offering.
[3] On August 23, 2017, the Company issued 213,800 common stock warrants to underwriters as part of the overallotment attributed to the July 2017 underwritten public offering.
[4] As part of the underwritten public offering on July 19, 2017, the Company issued 134,000 common stock warrants to the underwriters as part of the services performed by them in connection with the underwritten public offering.
[5] On June 10, 2016, we issued two warrants, pursuant to a Finder's Fee Agreement with Maxim Group LLC, to purchase in aggregate 4,000 shares of Common Stock following the introduction of an accredited investor who entered into a Second Amended Note and Warrant Purchase Agreement in the principal amount of $200,000. Each warrant is exercisable, in whole or in part, during the period beginning on the date of its issuance, and ending on the earlier of (i) December 31, 2020 and (ii) the date that is forty-five (45) days following the date on which the daily closing price of shares of the Company's Common Stock quoted on the OTCQB Venture Marketplace (or other bulletin board or exchange on which the Company's Common Stock is traded or listed) exceeds $50.00 for at least ten (10) consecutive trading days. In connection therewith, the Company will promptly notify the Note Warrant holders in the event that the daily closing price of the Company's shares of Common Stock exceeds $50.00 for at least ten (10) consecutive trading days. Pursuant to the Finder's Fee Agreement, Maxim was also paid $20,000 cash for their efforts.